Turn Therapeutics (TTRX) Other Operating Expenses (2025 - 2026)
Turn Therapeutics' (TTRX) quarterly Other Operating Expenses came in at -$286126.0 in Q1 2026, down 153.36% year-on-year from $536182.4 in Q1 2025, and down 931.31% quarter-over-quarter from -$27744.0 in Q4 2025.
Turn Therapeutics (TTRX) Other Operating Expenses (2025 - 2026) Analysis & Trends
Turn Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at -$286126.0 for Q1 2026.
- On a quarterly basis, Other Operating Expenses fell 153.36% year-over-year to -$286126.0 in Q1 2026; TTM through Mar 2026 was -$426801.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$928562.0, down 190.02% from the prior year.
- Other Operating Expenses fell to -$286126.0 in Q1 2026 per TTRX's latest filing, from -$27744.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at -$27744.0 in Q4 2025 and bottomed at -$286126.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Turn Therapeutics | 253.20 Mn | 253.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -286,126.00 |
| Dec 31, 2025 | -27,744.00 |
| Mar 31, 2025 | -112,931.00 |